§ EQUITY
USDCBIO
CRESCENT BIOPHARMA INC
USD
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
50 increased/new, 17 decreased/exited (13F)
AC 13F Analysis
ANALYST
13 buy, 2 hold, 0 sell
Finnhub
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Fidelity Management | 4.1M | 0.0% | ±0% |
| BVF INC/IL | 2.7M | 1.6% | ±0% |
| Fairmount Funds Management LLC | 2.7M | 3.6% | ±0% |
| Venrock Adviser, LLC | 2.1M | 1.5% | ±0% |
| FCPM III SERVICES B.V. | 1.7M | 4.3% | ±0% |
| Balyasny Asset Management | 1.5M | 0.0% | +1252% |
◇ AC INTELLIGENCE
Top institutional owners for CBIO as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER73.7% · 42 holders
QUALITY / COMPOUNDER15.6% · 2 holders
TACTICAL / MACRO7.0% · 3 holders
DEALER / BANK1.9% · 11 holders
SYSTEMATIC / QUANT0.8% · 2 holders
PASSIVE / INDEX0.8% · 2 holders
INCOME / DEFENSIVE0.1% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for CBIO in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention CBIO yet.